Does Preference-based HIV Testing Increase Uptake in High Risk Populations?
DCE-IMPACT
1 other identifier
interventional
1,194
2 countries
3
Brief Summary
Despite worldwide efforts to promote HIV Counseling and Testing (HCT), rates of testing remain low. Understanding how high risk groups decide to test and adapting available testing options to their preferences has the potential to broadly improve HCT uptake and cost-effectiveness. This study proposes to use a Discrete Choice Experiment, a survey method increasingly used by health economists for the design of patient-centered health care options, to rigorously quantify HIV testing preferences among two high-risk populations, identify their preferred testing options, and evaluate, in a pragmatic randomized controlled trial (RCT), the effect of a preference-based HIV counseling and testing (PB-HCT) intervention on testing uptake. At a time of heightened focus on health preferences research and patient-centered care, this study evaluates the critical link between preference-based intervention design and efficacy. If the RCT indicates that PB-HCT increases testing rates, the testing options evaluated in this R01 can be offered to high-risk populations in the study area, and the preference elicitation method and tools can be used to inform the design of testing options that better match the preferences of other high-risk populations and in other settings.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2018
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 16, 2016
CompletedFirst Posted
Study publicly available on registry
March 21, 2016
CompletedStudy Start
First participant enrolled
January 3, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2020
CompletedAugust 18, 2021
August 1, 2021
2.8 years
March 16, 2016
August 11, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Uptake of HIV testing - 3 months
Percent of participants who test for HIV
3 months
Secondary Outcomes (1)
Uptake of HIV testing - 15 months
15 months
Study Arms (3)
Group A: More preferred Existing + Common
EXPERIMENTALGroup A participants will be offered the common option and 3 currently available testing options that are targeted at the distribution of preferences among participants.
Group B: More preferred Enhanced + Common
EXPERIMENTALGroup B participants will be offered the common option and 3 preference-informed "enhanced" testing options, which include combinations of features that may not yet be available in the study area.
Group C: Less preferred + Common
ACTIVE COMPARATORGroup C participants will be offered the common option and 3 predicted less-preferred options. With the common option being the best option in Group C, this group is effectively a non-PB-HCT comparison group.
Interventions
Participants will be offered 3 HIV testing options. The investigators will rank the predicted utility of all feasible ENHANCED HIV testing options for each participant and select those 3 PB-HCT options that jointly maximize the share of participants predicted to prefer at least one of the three options over the common option.
Participants will be re-contacted three months after being offered PB-HCT options. Participants will be reminded of the options, and offered an incentive to present for testing using any of the PB-HCT options or the common option.
Participants will receive an SMS reminder to test.
Eligibility Criteria
You may qualify if:
- Males who work as Kilimanjaro mountain porters, Females who regularly work at a bar, hotel or restaurant establishment and serve alcohol to patrons.
- Eligible participants will be ages 18+, reside in Moshi, Tanzania and have no plans to leave the study area.
You may not qualify if:
- Participants who are not able to see will be excluded owing to the visual nature of the survey presented to elicit preferences.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of South Carolinalead
- Duke Universitycollaborator
- Kilimanjaro Christian Medical Centre, Tanzaniacollaborator
Study Sites (3)
Duke University
Durham, North Carolina, 27708, United States
University of South Carolina
Columbia, South Carolina, 29208, United States
Kilimanjaro Clinical Research Institute
Moshi, Kilimanjaro, Tanzania
Related Publications (7)
Ostermann J, Njau B, Brown DS, Muhlbacher A, Thielman N. Heterogeneous HIV testing preferences in an urban setting in Tanzania: results from a discrete choice experiment. PLoS One. 2014 Mar 18;9(3):e92100. doi: 10.1371/journal.pone.0092100. eCollection 2014.
PMID: 24643047BACKGROUNDNjau B, Ostermann J, Brown D, Muhlbacher A, Reddy E, Thielman N. HIV testing preferences in Tanzania: a qualitative exploration of the importance of confidentiality, accessibility, and quality of service. BMC Public Health. 2014 Aug 12;14:838. doi: 10.1186/1471-2458-14-838.
PMID: 25124140BACKGROUNDOstermann J, Njau B, Mtuy T, Brown DS, Muhlbacher A, Thielman N. One size does not fit all: HIV testing preferences differ among high-risk groups in Northern Tanzania. AIDS Care. 2015;27(5):595-603. doi: 10.1080/09540121.2014.998612. Epub 2015 Jan 23.
PMID: 25616562BACKGROUNDOstermann J, Brown DS, Muhlbacher A, Njau B, Thielman N. Would you test for 5000 Shillings? HIV risk and willingness to accept HIV testing in Tanzania. Health Econ Rev. 2015 Dec;5(1):60. doi: 10.1186/s13561-015-0060-8. Epub 2015 Aug 19.
PMID: 26285777BACKGROUNDOstermann J, Njau B, Hobbie A, Mtuy T, Masaki ML, Shayo A, van Zwetselaar M, Masnick M, Flaherty B, Brown DS, Muhlbacher AC, Thielman NM. Using discrete choice experiments to design interventions for heterogeneous preferences: protocol for a pragmatic randomised controlled trial of a preference-informed, heterogeneity-focused, HIV testing offer for high-risk populations. BMJ Open. 2020 Nov 6;10(11):e039313. doi: 10.1136/bmjopen-2020-039313.
PMID: 33158826BACKGROUNDOstermann J, Njau B, Hobbie AM, Mtuy TB, Masnick M, Brown DS, Muhlbacher AC, Thielman NM. Divergent preferences for enhanced HIV testing options among high-risk populations in northern Tanzania: a short report. AIDS Care. 2023 Sep;35(9):1270-1278. doi: 10.1080/09540121.2022.2119471. Epub 2022 Sep 5.
PMID: 36063533DERIVEDOstermann J, Njau B, Masaki M, Mtuy T, Itemba D, Hobbie A, Yelverton V, Moore S, Yamanis T, Thielman NM. Feasibility, Acceptability, and Potential Cost-Effectiveness of a Novel Mobile Phone Intervention to Promote Human Immunodeficiency Virus Testing Within Social Networks in Tanzania. Sex Transm Dis. 2022 Nov 1;49(11):778-781. doi: 10.1097/OLQ.0000000000001611. Epub 2022 Jan 29.
PMID: 35093981DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Jan Ostermann, PhD
University of South Carolina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
March 16, 2016
First Posted
March 21, 2016
Study Start
January 3, 2018
Primary Completion
October 31, 2020
Study Completion
October 31, 2020
Last Updated
August 18, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share